RankingsPricing
  1. JP-listed companies
  2. SAPPORO CLINICAL LABORATORY INC.
  3. Financials
  4. Capital expenditures

SAPPORO CLINICAL LABORATORY INC.JP:9776

Market cap
¥8.3B
P/E ratio
12.2x
SummaryFinancialsHistoryOwnershipWorkforce
Period EndCapital expenditures (Million JPY)YoY (%)
Mar 31, 2025-1,222+214.64%
Mar 31, 2024-388-52.11%
Mar 31, 2023-811-3.22%
Mar 31, 2022-838-73.33%
Mar 31, 2021-3,142+5.65%
Mar 31, 2020-2,974+1123.02%
Mar 31, 2019-243-19.05%
Mar 31, 2018-300-44.93%
Mar 31, 2017-546+15.19%
Mar 31, 2016-474+51.17%
Mar 31, 2015-313

Income Statement

RevenueRevenue growth (%)Cost of revenueGross profitGross margin (%)Research & developmentSelling, general & administrativeOperating margin (%)Operating income Operating expenses Income before tax Pretax margin (%)Provision for income taxesEffective tax rate (%)Net income Net income margin (%)Earnings per shareDiluted EPSAdjusted EPSDividend payout ratio (%)Dividend per shareAdjusted DPSEBITDAEBITDA margin (%)

Balance Sheet

Cash and cash equivalents Marketable securities, current Total cash & short-term investmentsAccounts receivable, netInventoriesTotal current assetsProperty, plant and equipment, netMarketable securities, non-current Total non-current assetsTotal assets Accounts payableShort-term debtLong-term debt, current Total current liabilitiesLong-term debt, non-current Total non-current liabilitiesTotal liabilities Common stock and paid-in capital Retained earningsStockholders' equityTotal debtNet debtD/E ratio (%)Working capital

Cash Flow

Depreciation & amortizationStock-based compensationCash from operations Capital expendituresCash from investing Payments for dividends Repurchases of common stockProceeds from issuance of term debt, netRepayments of term debtCash from financing Free cash flowFCF margin (%)